According to the Qichacha app, recently, Zhejiang Aobei Biomedical Technology Co., Ltd. was established, with Lou Jinfang as its legal representative and a registered capital of 10 million yuan. Its scope of business includes the development of human gene diagnosis and treatment technology, production of new chemical substances, and provision of pharmaceutical internet-related information services. According to Qichacha's equity penetration, the company is wholly owned by Baicheng Pharmaceuticals.
百诚医药在浙江成立生物医药科技公司
Baicheng Pharmaceuticals established a biomedical technology company in Zhejiang.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.